ES469822A1 - Pharmaceutical preparation of stable prostaglandine - Google Patents

Pharmaceutical preparation of stable prostaglandine

Info

Publication number
ES469822A1
ES469822A1 ES469822A ES469822A ES469822A1 ES 469822 A1 ES469822 A1 ES 469822A1 ES 469822 A ES469822 A ES 469822A ES 469822 A ES469822 A ES 469822A ES 469822 A1 ES469822 A1 ES 469822A1
Authority
ES
Spain
Prior art keywords
prostaglandine
stable
pharmaceutical preparation
pge
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES469822A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of ES469822A1 publication Critical patent/ES469822A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE:Prostablandin E (PGE) having vasodilating and tracheaectasy effects, is dissolved in an aqueous solution containing an alkylene glycol that is solid at room temperature, and freeze-dried to produce said PGE preparation of high storage stability.
ES469822A 1977-05-12 1978-05-12 Pharmaceutical preparation of stable prostaglandine Expired ES469822A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52054679A JPS6019734B2 (en) 1977-05-12 1977-05-12 Method for producing stable prostaglandin E preparations

Publications (1)

Publication Number Publication Date
ES469822A1 true ES469822A1 (en) 1978-12-16

Family

ID=12977466

Family Applications (1)

Application Number Title Priority Date Filing Date
ES469822A Expired ES469822A1 (en) 1977-05-12 1978-05-12 Pharmaceutical preparation of stable prostaglandine

Country Status (7)

Country Link
JP (1) JPS6019734B2 (en)
CA (1) CA1090255A (en)
CH (1) CH635513A5 (en)
DK (1) DK210778A (en)
ES (1) ES469822A1 (en)
NL (1) NL7805180A (en)
SE (1) SE435898B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
US4409239A (en) * 1982-01-21 1983-10-11 Syntex (U.S.A.) Inc. Propylene glycol diester solutions of PGE-type compounds
DE19541815B4 (en) * 1995-11-09 2008-04-10 Bannert, Christian, Dr. Use of a solution of polyethylene glycol in water as an aqueous rinse solution for the prevention or treatment of viscous mucus associated with radiation and / or chemotherapy-induced mucosal disorders
DE102004019743B4 (en) 2004-04-20 2008-11-27 Bayer Schering Pharma Aktiengesellschaft Multiphase preparation for contraception based on natural estrogen
AT515356B1 (en) * 2014-01-30 2015-11-15 Gebro Holding Gmbh Stable alcoholic solution of alprostadil

Also Published As

Publication number Publication date
JPS6019734B2 (en) 1985-05-17
SE435898B (en) 1984-10-29
NL7805180A (en) 1978-11-14
SE7805499L (en) 1978-11-13
CA1090255A (en) 1980-11-25
JPS53139716A (en) 1978-12-06
DK210778A (en) 1978-11-13
CH635513A5 (en) 1983-04-15

Similar Documents

Publication Publication Date Title
ES8201419A1 (en) Aqueous solution of nitroglycerin
SE7903817L (en) MORANOLIN DERIVATIVES
JPS51148013A (en) Stable insulin preparation for nosal administration
ES479615A1 (en) Antiviral amine derivatives of glycerol and propanediols
NZ178014A (en) Stable sulphonate salts and sulphonate-sulphuric acid double salts of s-adenosil-l-methionine
JPS5238017A (en) Immunological medicine being active in aqueous solution
FI854167A0 (en) MUN- OCH TANDVAORMEDEL.
ES460743A1 (en) Preserving liquid antacid medicinal formulations
IL58080A (en) Acid addition salts of 16beta-monoquaternary ammonium derivatives of 2beta,16beta-bis-piperidino-androstanes and pharmaceutical compositions containing them
GB1262785A (en) Improvements in or relating to phloroglucinol derivatives
ES469822A1 (en) Pharmaceutical preparation of stable prostaglandine
ES518636A0 (en) PROCEDURE TO IMPROVE TOBACCO FILLING CAPACITY.
JPS5218811A (en) Preparation of aqueous solution of fat- soluble substances
IT1066034B (en) POLYTHRIAZINES STABLE TO HYDROLYSIS AND PROCEDURE TO PRODUCE THEM
JPS5262390A (en) Solution of high storage stability and its using method
JPS5218832A (en) Method of making cosmetic preparation
JPS5282709A (en) Preparation of insulinnlike active substance
ES459244A1 (en) Sustained release ophthalmic pharmaceutical preparations containing collagens
JPS5318529A (en) Optically active mandelic acid phenylglycinol salt and its preparation
GB739800A (en) Aqueous pharmaceutical solutions of reserpine for parenteral administration
ES451555A1 (en) Shampoo composition
SE426059B (en) PROCEDURE FOR PREPARING PURE GRAPHIC ACID AND MESOVIC ACID
SU466021A1 (en) Antidrug
JPS5341418A (en) Preparation of antibiotic preparations of aminoglycoside series suitable for rectal administration
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19941121